Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Barbital

Related Products

Hot Products

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.
Name

Barbital

EINECS 200-331-2
CAS No. 57-44-3 Density 1.14 g/cm3
PSA 75.27000 LogP 0.81640
Solubility 7.149g/L(25 oC) Melting Point 188-192°C
Formula C8H12N2O3 Boiling Point 318.14°C (rough estimate)
Molecular Weight 184.195 Flash Point 11 °C
Transport Information N/A Appearance odorless, slightly bitter, white crystalline powder
Safety 36/37 Risk Codes 20-40-63
Molecular Structure Molecular Structure of 57-44-3 (BARBITAL) Hazard Symbols HarmfulXn
Synonyms

Barbituricacid, 5,5-diethyl- (8CI);5,5-Diethyl-2,4,6(1H,3H,5H)-pyrimidinetrione;5,5-Diethylbarbituric acid;5,5-Diethylhexahydropyrimidine-2,4,6-trione;Barbital;Barbitone;Deba;Diemal;Diethylbarbitone;Diethylbarbituric acid;Diethylmalonylurea;Dormonal;Ethylbarbital;Hypnogene;Malonal;NSC 31352;Sedeval;Uronal;Veroletten;Veronal;Veronal acetate;Vesperal;

Article Data 84

Barbital Consensus Reports

EPA Genetic Toxicology Program.

Barbital Specification

The Barbital, with the CAS registry number 57-44-3 and EINECS registry number 200-331-2, has the IUPAC name of 5,5-diethyl-1,3-diazinane-2,4,6-trione. It is also known as Veronal, and it is a kind of odorless, slightly bitter, white crystalline powder. And the molecular formula of this chemical is C8H12N2O3. What's more, it should be stored at 2-8°C.

The physical properties of Barbital are as followings: (1)ACD/LogP: 0.80; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 0.802; (4)ACD/LogD (pH 7.4): 0.69; (5)ACD/BCF (pH 5.5): 2.394; (6)ACD/BCF (pH 7.4): 1.851; (7)ACD/KOC (pH 5.5): 64.949; (8)ACD/KOC (pH 7.4): 50.212; (9)#H bond acceptors: 5; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 2; (12)Polar Surface Area: 75.27 Å2; (13)Index of Refraction: 1.458; (14)Molar Refractivity: 44.093 cm3; (15)Molar Volume: 161.588 cm3; (16)Polarizability: 17.48×10-24cm3; (17)Surface Tension: 33.632 dyne/cm; (18)Density: 1.14 g/cm3.

Synthesis of Barbital: It can be synthesized in a condensation reaction from urea and a diethyl malonate derivative:

Barbital can be synthesized by urea and a diethyl malonate derivative

Uses of Barbital: It is usually used as a sleeping aid. But it had few side effects: prolonged usage resulted in tolerance to the drug. And it is also used in buffer solution.

You should be cautious while dealing with this chemical. It is harmful by inhalation, and may cause carcinogenic effect. It is also harmul to the unborn child. Therefore, you had better wear suitable protective clothing and gloves.

You can still convert the following datas into molecular structure:
(1)SMILES: CCC1(C(=O)NC(=O)NC1=O)CC
(2)InChI: InChI=1/C8H12N2O3/c1-3-8(4-2)5(11)9-7(13)10-6(8)12/h3-4H2,1-2H3,(H2,9,10,11,12,13)
(3)InChIKey: FTOAOBMCPZCFFF-UHFFFAOYAR

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LDLo oral 250mg/kg (250mg/kg) BEHAVIORAL: ATAXIA

BEHAVIORAL: REGIDITY

BEHAVIORAL: ANALGESIA
Journal of Pharmacology and Experimental Therapeutics. Vol. 33, Pg. 43, 1928.
chicken LDLo intravenous 225mg/kg (225mg/kg)   Physiological Reviews. Vol. 19, Pg. 472, 1939.
mouse LD50 intraperitoneal 178mg/kg (178mg/kg)   Farmaco, Edizione Scientifica. Vol. 14, Pg. 269, 1959.
mouse LD50 oral 600mg/kg (600mg/kg)   Drugs in Japan Vol. 6, Pg. 590, 1982.
mouse LD50 subcutaneous 630mg/kg (630mg/kg) BEHAVIORAL: SLEEP

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Yakugaku Zasshi. Journal of Pharmacy. Vol. 74, Pg. 122, 1954.
rabbit LDLo intraperitoneal 225mg/kg (225mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 44, Pg. 325, 1932.
rabbit LDLo intravenous 350mg/kg (350mg/kg)   Journal de Physiologie et de Pathologie Generale. Vol. 30, Pg. 364, 1932.
rabbit LDLo oral 275mg/kg (275mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 44, Pg. 325, 1932.
rabbit LDLo subcutaneous 250mg/kg (250mg/kg)   Journal of the American Chemical Society. Vol. 45, Pg. 243, 1923.
rat LD50 intraperitoneal 246mg/kg (246mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Pharmazie. Vol. 8, Pg. 913, 1953.
rat LD50 subcutaneous 450mg/kg (450mg/kg)   Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 152, Pg. 341, 1930.